Brain's own opioids may power placebo effect for heartbreak and pain
NCT ID NCT04650841
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-phase study investigates whether the opioid system is involved in placebo effects on both physical pain and the pain of social rejection. Sixty adults who recently experienced an unwanted breakup will receive either naloxone (which blocks opioids) or saline, and be told it is either a pain-reducing spray or a placebo. During brain scans, they will be exposed to heat, pressure, and rejection-related stimuli to measure pain, emotions, and brain activity.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- naloxone nasal spray
- What this could lead to
- If successful, this could help explain how the brain's natural opioids contribute to placebo effects, potentially guiding future treatments for pain and social distress.
- What could go wrong
- This is a very early, small study (60 people) focused on understanding mechanisms, not testing a treatment. Results may not apply to broader populations or lead directly to therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Early phase 1
The earliest testing in people: a first look at safety, in a very small group.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Mar 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 55 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults aged 18-55 years * No current psychiatric or major neurological diagnosis * No reported substance abuse within the last six months * Are capable of performing experimental tasks (e.g., are able to read, able to cooperate with fMRI examination) * Are fluent or native speakers of English * No current or recent history of pathological pain or reported neurological disorders. * Having abstained from alcohol and substance use for 48 hours * Passed fMRI safety screener * Experienced a recent unwanted breakup of a romantic relationship Exclusion Criteria: * Current presence of pain * Current or past history of primary psychiatric disorder * Current or past history of psychoactive substance abuse or dependence * Dementias * Movement disorders except familial tremor * CNS infection * CNS vasculitis, inflammatory disease or autoimmune disease * CNS demyelinating disease (e.g. multiple sclerosis) * Space occupying lesions (mass lesions, tumors) * Congenital CNS abnormality (e.g. cerebral palsy) * Seizure disorder * History of closed head trauma with loss of consciousness * History of cerebrovascular disease (stroke, TIAs) * Abnormal MRI (except changes accounted for by technical factors or UBOs) * Neuroendocrine disorder (e.g., Cushings disease) * Uncorrected hypothyroidism or hyperthyroidism * Current or past history of cancer; Recent history (within two years) of myocardial infarction, severe cardiovascular disease, or currently active cardiovascular disease (e.g. angina, cardiomyopathy) * Uncontrolled hypertension or hypotension * Chronic pain syndromes * Chronic fatigue syndromes * Subjects unable to tolerate the scanning procedures (e.g., claustrophobia) * Prior treatment within the last month with any of the following: antidepressants, mood stabilizers, glucocorticoids, opiates * Prior treatment with any of the following: antipsychotics, isoniazid, centrally active antihypertensive drugs (e.g. clonidine, reserpine) * Metal in body or prior history working with metal fragments (e.g., as a machinist) * For women, pregnancy * Any other contraindications for MRI examination (e.g., metallic implants such as pacemakers, surgical aneurysm clips, or known metal fragments embedded in the body) * Claustrophobia
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pain are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Dartmouth College
Hanover, New Hampshire, 03755, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a finger sensor reveal whether an epidural is working?
- Five simple signs could help nurses score surgical pain in turkish
- Can green light glasses take the sting out of surgery?
- Can a Hands-On nerve technique ease Fibromyalgia's grip?
- Fixing broken ribs with surgery may cut pain better than drugs alone
- Could a Patient's playlist take the sting out of nerve testing?